TransMedics
NASDAQ: TMDXAndover, US · Delaware corporation · 2 known investors
Find your way into TransMedics
TransMedics develops and sells the Organ Care System (OCS), a portable warm perfusion platform for preserving and assessing donor hearts, lungs, and livers outside the body prior to transplantation, along with the National OCS Program, an end-to-end organ procurement and logistics service for transplant centers that includes aircraft and ground transportation. The company serves transplant centers, hospitals, and patients requiring organ transplants.
Founders & leadership
WH
Waleed H. HassaneininFounder
SG
Stephen GordonExecutive
Board
EM
Edwin M. Kania, Jr.Board director
DA
David AbramsBoard director
JS
Joseph S. LacobBoard director
TR
Travis RhodesBoard director
JR
James R. TobinBoard director
KB
Kenneth BateBoard director
EM
Earl M. Collier, Jr.Board director
TL
Tony Lee WhiteBoard director
Investors · 2
Reported raises · per SEC filings
Form D private placements$84.2M disclosed across 3 of 7 rounds · 1900–2016
▶$63.7MraisedJul 2016 · 20 investors · Other Health CareRule 506(b)
▶$63.7MraisedJul 2016 · 20 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Edward BasileDirector
- Travis RhodesDirector
- Waleed H. HassaneinExecutive Officer, Director
- Stephen GordonExecutive Officer
- James R. TobinDirector
- James GilbertDirector
- Dmitry KobyzevDirector
- Edwin M. Kania, Jr.Director
- David AbramsDirector
- Offering amount
- $63.7M
- Amount sold
- $63.7M
- First sale
- May 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$500KraisedSep 2015 · 1 investors · Other Health CareRule 506(b)
▶$500KraisedSep 2015 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Joseph S. LacobDirector
- David AbramsDirector
- Stephen GordonExecutive Officer
- Waleed H. HassaneinExecutive Officer, Director
- Travis RhodesDirector
- Earl M. Collier, Jr.Director
- Tony Lee WhiteDirector
- Kenneth BateDirector
- Edwin M. Kania, Jr.Director
- James R. TobinDirector
- Offering amount
- $500K
- Amount sold
- $500K
- First sale
- Sep 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$20MraisedJun 2015 · 11 investors · Other Health CareRule 506(b)
▶$20MraisedJun 2015 · 11 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Edwin M. Kania, Jr.Director
- Waleed H. HassaneinExecutive Officer, Director
- James R. TobinDirector
- Kenneth BateDirector
- David AbramsDirector
- Joseph S. LacobDirector
- Earl M. Collier, Jr.Director
- Travis RhodesDirector
- Tony Lee WhiteDirector
- Stephen GordonExecutive Officer
- Offering amount
- $20M
- Amount sold
- $20M
- First sale
- May 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Valuation · disclosed
Disclosed events$323.8Mvaluation at IPOMay 2019 · $16.00/share · 424B4
filing ↗Source: SEC prospectus filings, and round valuations the company or its investors disclosed — follow each entry's link for the claim.
In the news
Frequently asked questions
- What does TransMedics do?
- TransMedics develops and sells the Organ Care System (OCS), a portable warm perfusion platform for preserving and assessing donor hearts, lungs, and livers outside the body prior to transplantation, along with the National OCS Program, an end-to-end organ procurement and logistics service for transplant centers that includes aircraft and ground transportation. The company serves transplant centers, hospitals, and patients requiring organ transplants.
- Who founded TransMedics?
- TransMedics was founded by Waleed H. Hassanein.
- Who are TransMedics's investors?
- TransMedics's investors include Alta Partners, Flagship Pioneering.
- How much funding has TransMedics raised?
- TransMedics has disclosed $84.2M raised across 3 of its 7 known rounds.
- Where is TransMedics headquartered?
- TransMedics is headquartered in Andover, US.